Subscribe to this column
Don S. Dizon, MD, FACP, FASCO
Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon.
Jan 29, 2019
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
Dec 20, 2018
My patient's greatest fear was living in pain, so I called on my incredible colleagues in palliative care.
Dec 11, 2018
What do you do when a patient requests a different physician, and you suspect prejudice is the reason?
Nov 20, 2018
Although there are still several weeks left in 2018, events have left me speechless twice this year: the deaths of two women, well before their time.
Oct 30, 2018
How using the term "screen failure" can be a disservice to clinical trial teams and patients alike.
Sep 25, 2018
To be a truly good doctor, you can't just care for people - you have to care about people.
Latest Blogs